Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2022 Filed Mar 9, 2022 22:45 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 3,905 | $12.69 | $49,554.45 |
DisclosureSEC source: 0001209191-22-017649 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,534 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 22:43 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 7,081 | $12.69 | $89,857.89 |
DisclosureSEC source: 0001209191-22-017646 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,023 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:04 UTC |
Eisner MarkChief Medical Officer
|
Tax withholdingCommon Stock | 756 | $13.62 | $10,296.72 |
DisclosureSEC source: 0001209191-22-015366 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,383 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:05 UTC |
Wettig ThaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010459 · doc4.xml · derivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:05 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010459 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,682 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:03 UTC |
Graham JuanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010457 · doc4.xml · derivative · entry 2 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:03 UTC |
Graham JuanChief Financial Officer
|
GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010457 · doc4.xml · nonDerivative · entry 1 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,900 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:01 UTC |
Eisner MarkChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010452 · doc4.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 02:01 UTC |
Eisner MarkChief Medical Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010452 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,139 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:59 UTC |
Chung ChristineSVP, China Operations
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010449 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:59 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010449 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,439 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:57 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 298,000 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0001209191-22-010447 · doc4.xml · derivative · entry 3 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,000 Underlying: Common Stock · 298,000 shares Expires 2032-02-13 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option will vest on March 1, 2023, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 14, 2022 Filed Feb 17, 2022 01:57 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantCommon Stock | 179,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-010447 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,104 F1 · shares: Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2023, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 06, 2022 Filed Jan 7, 2022 22:37 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,536 | $13.93 | $21,396.48 |
DisclosureSEC source: 0001209191-22-002496 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,704 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes one share acquired on November 15, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:44 UTC |
Eisner MarkChief Medical Officer
|
Tax withholdingCommon Stock | 7,043 | $14.82 | $104,377.26 |
DisclosureSEC source: 0001209191-22-001743 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,139 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:41 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 5,284 | $14.82 | $78,308.88 |
DisclosureSEC source: 0001209191-22-001740 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,439 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 22:17 UTC |
Wettig ThaneChief Commercial Officer
|
Tax withholdingCommon Stock | 517 | $14.97 | $7,739.49 |
DisclosureSEC source: 0001209191-21-071114 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,682 F1 · shares: Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 3 shares acquired on November 15, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 21:02 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 2,668 | $14.19 | $37,858.92 |
DisclosureSEC source: 0001209191-21-068506 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,723 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:03 UTC |
Eisner MarkChief Medical Officer
|
Tax withholdingCommon Stock | 4,338 | $12.65 | $54,875.70 |
DisclosureSEC source: 0001209191-21-067780 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,182 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 21:03 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,859 | $10.20 | $18,961.80 |
DisclosureSEC source: 0001209191-21-060056 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,239 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:28 UTC |
Chung ChristineSVP, China Operations
|
GrantStock Option (Right to Buy) · Derivative | 32,360 | $0.00 Strike: $9.93 | $0.00 |
DisclosureSEC source: 0001209191-21-059871 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,360 Underlying: Common Stock · 32,360 shares Expires 2031-10-04 F2 · derivative.exercise_date: Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:28 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 54,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059871 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,391 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:25 UTC |
Eisner MarkChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,520 | $0.00 Strike: $9.93 | $0.00 |
DisclosureSEC source: 0001209191-21-059869 · doc4.xml · derivative · entry 2 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,520 Underlying: Common Stock · 44,520 shares Expires 2031-10-04 F2 · derivative.exercise_date: Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 23:25 UTC |
Eisner MarkChief Medical Officer
|
GrantCommon Stock | 74,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-059869 · doc4.xml · nonDerivative · entry 1 Eisner Mark · CIK 0001834161 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,520 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 20:02 UTC |
Wettig ThaneChief Commercial Officer
|
Tax withholdingCommon Stock | 620 | $10.18 | $6,311.60 |
DisclosureSEC source: 0001209191-21-057566 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,196 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 20:02 UTC |
KEARNS THOMAS F JRDirector
|
SaleCommon Stock | 13,100 | $11.58 | $151,707.17 |
DisclosureSEC source: 0001209191-21-056604 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,764 F1 · price: These shares were sold in multiple transactions on the reported date with prices ranging from $11.46 to $11.615 resulting in a weighted average price of $11.5807. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction. Read SEC document |
| September 07, 2021 Filed Sep 10, 2021 01:35 UTC |
Cotroneo PatExecutive Advisor & Former CFO
|
Tax withholdingCommon Stock | 2,141 | $12.41 | $26,569.81 |
DisclosureSEC source: 0001209191-21-055405 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · Executive Advisor & Former CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,536 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 07, 2021 Filed Sep 10, 2021 01:33 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 2,030 | $12.41 | $25,192.30 |
DisclosureSEC source: 0001209191-21-055403 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,251 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| September 07, 2021 Filed Sep 10, 2021 01:32 UTC |
Graham JuanChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 196,000 | $0.00 Strike: $12.41 | $0.00 |
DisclosureSEC source: 0001209191-21-055402 · doc4.xml · derivative · entry 2 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,000 Underlying: Common Stock · 196,000 shares Expires 2031-09-07 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on September 7, 2022, and the remainder vests in equal amount quarterly thereafter for the following three years. Read SEC document |
| September 07, 2021 Filed Sep 10, 2021 01:32 UTC |
Graham JuanChief Financial Officer
|
GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-055402 · doc4.xml · nonDerivative · entry 1 Graham Juan · CIK 0001879223 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,400 F1 · shares: Represents that grant of restricted stock units. Twenty-five percent of the restricted stock units vest on September 7, 2022, and the remainder vests in equal amount quarterly thereafter for the following three years. Read SEC document |
| August 26, 2021 Filed Aug 31, 2021 00:11 UTC |
Wettig ThaneChief Commercial Officer
|
PurchaseCommon Stock | 3,100 | $11.53 | $35,743.00 |
DisclosureSEC source: 0001209191-21-053980 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,816 Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 00:31 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 1,859 | $25.06 | $46,586.54 |
DisclosureSEC source: 0001209191-21-046078 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,098 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:27 UTC |
Wettig ThaneChief Commercial Officer
|
Tax withholdingCommon Stock | 2,593 | $27.65 | $71,696.45 |
DisclosureSEC source: 0001209191-21-043157 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,716 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 1,159 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 01:25 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 4,053 | $25.62 | $103,837.86 |
DisclosureSEC source: 0001209191-21-041808 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,677 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:29 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 2,141 | $22.90 | $49,028.90 |
DisclosureSEC source: 0001209191-21-039294 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,730 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 23:26 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 2,030 | $22.90 | $46,487.00 |
DisclosureSEC source: 0001209191-21-039293 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,251 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on May 14, 2021 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:09 UTC |
Schoeneck James ADirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036684 · doc4.xml · derivative · entry 3 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:09 UTC |
Schoeneck James ADirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036684 · doc4.xml · nonDerivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:08 UTC |
RIGGS RORY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036683 · doc4.xml · derivative · entry 3 RIGGS RORY B · CIK 0001016835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F3 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:08 UTC |
RIGGS RORY BDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036683 · doc4.xml · nonDerivative · entry 1 RIGGS RORY B · CIK 0001016835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 395,750 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC |
Lema GeraldDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036682 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC |
Lema GeraldDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036682 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC |
Kurkijarvi KaleviDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036681 · doc4.xml · derivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:07 UTC |
Kurkijarvi KaleviDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036681 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,800 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:06 UTC |
KEARNS THOMAS F JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036679 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F3 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:06 UTC |
KEARNS THOMAS F JRDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036679 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,864 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC |
Ho MaykinDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036678 · doc4.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC |
Ho MaykinDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036678 · doc4.xml · nonDerivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,955 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC |
Henderson Jeffrey WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036677 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:05 UTC |
Henderson Jeffrey WilliamDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036677 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.